Recombinant Human EphA5 Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 3036-A5
Key Product Details
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human EphA5 protein
Ser56-Pro573, with a C-terminal 6-His tag
Ser56-Pro573, with a C-terminal 6-His tag
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ser56
Predicted Molecular Mass
58.4 kDa
SDS-PAGE
75-85 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
Immobilized Recombinant Human EphA5 at 2 µg/mL (100 µL/well) can bind recombinant mouse Ephrin-A2 Fc Chimera with a linear range of 0.16-10 ng/mL.
Immobilized Recombinant Human EphA5 at 2 µg/mL (100 µL/well) can bind recombinant mouse Ephrin-A2 Fc Chimera with a linear range of 0.16-10 ng/mL.
Formulation, Preparation and Storage
3036-A5
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: EphA5
References
- Poliakov, A. et al. (2004) Dev. Cell 7:465.
- Surawska, H. et al. (2004) Cytokine Growth Factor Rev 15:419.
- Pasquale, E.B. (2005) Nat. Rev. Mol. Cell Biol. 6:462.
- Davy, A. and P. Soriano (2005) Dev. Dyn. 232:1.
- Fox, G.M. et al. (1995) Oncogene 10:897.
- Miescher, G.C. et al. (1997) Mol. Brain Res. 46:17.
- Olivieri, G. and G.C. Miescher (1999) J. Histochem. Cytochem. 47:855.
- Taylor, V. et al. (1994) Neuroscience 63:163.
Alternate Names
Bsk, Cek7, Ehk1, Hek7, Rek7
Gene Symbol
EPHA5
UniProt
Additional EphA5 Products
Product Documents for Recombinant Human EphA5 Protein, CF
Product Specific Notices for Recombinant Human EphA5 Protein, CF
For research use only
Loading...
Loading...
Loading...